All Stories

  1. Emerging therapies in rheumatoid arthritis: focus on monoclonal antibodies

    Article • F1000Research, August 2019, Faculty of 1000, Ltd.

    Ladislav Senolt

  2. Efficacy and Safety of Anti-Interleukin-20 Monoclonal Antibody in Patients With Rheumatoid Arthritis: A Randomized Phase IIa Trial

    Article • Arthritis & Rheumatology, May 2015, Wiley

    Brian Bekker Hansen, Ladislav Senolt